Higher risk of preeclampsia and pregnancy-induced hypertension as a result of embryo freezing for IVF

Researchers have established a strong association between the risk of developing hypertension and preeclampsia and the artificial cycle for frozen-thawed embryo transfer.


IVF. Image Credit: Maxx-Studio/Shutterstock.com

Nearly 5% increased risk of both hypertension and pre-eclampsia when choosing embryonic cryopreservation

In vitro fertilization (IVF) is a common practice to overcome fertility problems and consists of removing an egg from the woman’s ovaries that is then fertilized in vitro to become an embryo, which is then returned to the woman’s womb to develop.

During this process, embryos can be frozen during embryonic cryopreservation, allowing individuals to store multiple embryos for transplantation at a later date. Embryo freezing is an increasingly common practice in recent years due to the higher success rates observed in frozen-thawed embryo transfers and because frozen transfers appear to reduce the risk of hyperstimulation.

However, a new study encompassing data from almost 70,000 pregnancies has shown that the embryo cryopreservation process is associated with a higher risk of maternal blood pressure issues.

The study categorized pregnancies from IVF and ICSI in the French national database into three groups: those derived from frozen embryo transfer in a natural "ovulatory" cycle (n = 9,500); those from frozen embryo transfer with hormone replacement therapy (n = 10,373); and conventional fresh transfers (n = 48,152).

After controlling for potentially confounding behavioral biases, the analysis demonstrated that women experienced a higher rate of pre-eclampsia with frozen embryos transferred in the artificial (i.e., prepared with hormone therapy) frozen cycle (5.3%) than in an ovulatory cycle (2.3%) or in fresh cycles (2.4%).

Moreover, the rates were also similar across groups when considering pregnancy-induced hypertension (4.7% vs 3.4% vs 3.3%).

Hormone replacement therapy ahead of embryo transfer puts patients at risk

The results were presented today by Dr. Sylvie Epelboin from the Hôpital Bichat-Claude Bernard, Paris, at the annual meeting of ESHRE and were performed on behalf of the Mother & child health after ART network, of the French Biomedicine Agency.

Dr. Sylvie Epelboin describes that findings highlight two key considerations in IVF: the potentially harmful effects on vascular pathologies of high and prolonged doses of hormone replacement therapies used to prepare the uterus for the implantation of frozen-thawed embryos; and the protective effect of a corpus luteum.

Hormone replacement therapy is given to prepare the uterus for embryo transfer, explained Dr. Epelboin, and is used to suppress ovulation and therefore the formation of the corpus luteum. The corpus luteum is a naturally developing cell cluster formed in the ovary during early pregnancy, which produces progesterone supporting the lining of the uterus (endometrium) during pregnancy and improves blood flow.

Therefore, the hormone replacement treatment could be interfering with progesterone function and leading to a higher risk of pregnancy-related disorders.

Amounting evidence has been raised in previous studies but the overall risks of maternal morbidity are known to be generally lower in pregnancies resulting from frozen embryo transfer than in those from fresh transfers - except in relation to the risk of vascular disorders such as preeclampsia.

Dr. Epelboin and colleagues concluded that the study demonstrates that preparation of the uterus with hormones in an artificial cycle is significantly associated with a higher risk of vascular disorders than from cycles with preserved ovulation and fresh embryo transfers.

Additional research investigating the exact hormonal mechanisms at play may provide further insights into potential treatments.

For instance, as the results obtained in an ovulatory cycle appear not to affect the chance of pregnancy, preservation of the ovulatory cycle could be advocated as first-line preparation in frozen embryo transfers whenever the choice is possible. Developing suitable alternatives may therefore be the key to reducing the risk of pregnancy-related disorders.

James Ducker

Written by

James Ducker

James completed his bachelor in Science studying Zoology at the University of Manchester, with his undergraduate work culminating in the study of the physiological impacts of ocean warming and hypoxia on catsharks. He then pursued a Masters in Research (MRes) in Marine Biology at the University of Plymouth focusing on the urbanization of coastlines and its consequences for biodiversity.  


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Ducker, James. (2021, June 30). Higher risk of preeclampsia and pregnancy-induced hypertension as a result of embryo freezing for IVF. News-Medical. Retrieved on July 17, 2024 from https://www.news-medical.net/news/20210630/Higher-risk-of-preeclampsia-and-pregnancy-induced-hypertension-as-a-result-of-embryo-freezing-for-IVF.aspx.

  • MLA

    Ducker, James. "Higher risk of preeclampsia and pregnancy-induced hypertension as a result of embryo freezing for IVF". News-Medical. 17 July 2024. <https://www.news-medical.net/news/20210630/Higher-risk-of-preeclampsia-and-pregnancy-induced-hypertension-as-a-result-of-embryo-freezing-for-IVF.aspx>.

  • Chicago

    Ducker, James. "Higher risk of preeclampsia and pregnancy-induced hypertension as a result of embryo freezing for IVF". News-Medical. https://www.news-medical.net/news/20210630/Higher-risk-of-preeclampsia-and-pregnancy-induced-hypertension-as-a-result-of-embryo-freezing-for-IVF.aspx. (accessed July 17, 2024).

  • Harvard

    Ducker, James. 2021. Higher risk of preeclampsia and pregnancy-induced hypertension as a result of embryo freezing for IVF. News-Medical, viewed 17 July 2024, https://www.news-medical.net/news/20210630/Higher-risk-of-preeclampsia-and-pregnancy-induced-hypertension-as-a-result-of-embryo-freezing-for-IVF.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exposure to fine particulate matter can reduce IVF birth rate success, study reveals